“…High altitude sickness is a growing concern due to the increased number of travelers, sportspersons, adventurers, pilgrims, army personnel, and even non‐resident locals living at high altitude >2,500 m (Kapoor, Narula, & Anand, 2004; Paralikar & Paralikar, 2010). Mild to life‐threatening clinical conditions such as acute mountain sickness (AMS), high altitude pulmonary edema (HAPE), high altitude cerebral edema (HACE), and High‐altitude pulmonary hypertension (HAPH), have been reported (Kapoor et al, 2004) at high altitude. The physiological effects of high altitude begin at 1,500–3,500 m (m) and gradually increase at 3,500–5,500 m and become severe at extremely high altitude (above 5,500 m) (Paralikar & Paralikar, 2010).…”